Home » Topics » Regulatory » EMA

EMA
RSS

Amgen, Allergan receive positive opinion in E.U. for ABP-980

March 26, 2018

EMA recommends including new indication in Repatha label

March 26, 2018

EMA committee issues negative opinion on Portola's betrixaban

March 26, 2018

Juluca receives positive opinion from EMA's CHMP

March 26, 2018

EMA committee backs approval of Sandoz's biosimilar infliximab

March 26, 2018

EMA committee hands down positive opinion for Cabometyx

March 23, 2018

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

EMA reports negative CHMP assessment for abaloparatide-SC

March 23, 2018

Immunicum obtains ATMP certificate from EMA for ilixadencel

March 21, 2018

EMA accepts type II variation application for Xtandi in non-metastatic CRPC

March 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...